MarginsXMarginsX
Home › Markets › Health Care › TELO

Telomir Pharmaceuticals Inc. (TELO)

TELO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.4810
-1.96% on the day
Market cap
$35.4M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerTELO on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2024
SEC CIK0001971532
SEC industry codePharmaceutical Preparations
Incorporated inFL

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
11.8 months
$4.5M cash at September 30, 2026
Share count, 1 year
+114.3%
2025-11-07 to 2026-11-05
Going-concern doubt
Yes
10-Q filed November 6, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the issuance date of this Report."
10-Q 2026-11-06
Cash and burn$4.5M cash; operating cash flow -$1.1M a quarter.Report 2026-09-30
Shares outstanding73,675,706 (2026-11-05); 34,380,971 a year earlier.Cover page 2026-11-05
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-10-27
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-01-12
AuditorSalberg & Company, P.A., Boca Raton, Florida, United States; changed auditors 1 time in 24 months8-K 4.01 2024-12-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$705K-$586K$4.5M$69KNeeds four quarters10-Q 2026-11-06
Q2 2026
2026-06-30
Not filed-$1.7M-$1.0M$5.2M$136KNeeds four quarters10-Q 2026-11-06
Q1 2026
2026-03-31
Not filed-$991K-$1.8M$5.6M$203KNeeds four quarters10-Q 2026-11-06
Q4 2025
2025-12-31
Not filed-$2.1M-$1.2M$7.3MNo debt tagsNeeds four quarters10-K 2026-03-17
Q3 2025
2025-09-30
Not filed-$1.1M-$927K$7.3MNo debt tagsNeeds four quarters10-Q 2026-11-06
Q2 2025
2025-06-30
Not filed-$5.1M-$696K$754KNo debt tagsNeeds four quarters10-Q 2026-11-06
Q1 2025
2025-03-31
Not filed-$2.2M-$863K$403KNo debt tagsNeeds four quarters10-Q 2026-11-06
Q4 2024
2024-12-31
Not filed-$2.9M-$606K$1.3MNo debt tagsNeeds four quarters10-K 2026-03-17

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-11-05
Latest annual report10-K2026-03-17
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-10-06
Latest proxyDEFA14A2026-08-19

Source: SEC EDGAR submissions feed, 150 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-30.8%
1 month-55.0%
3 months-53.2%
Year to date-63.1%
1 year-62.2%
From 52-week high-67.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
VERUVeru Inc.$2.08-0.48%$35.5M
OSTXOS Therapies Incorporated$0.6807-8.63%$35.4M
ATHEAlterity Therapeutics Limited$1.960.00%$35.7M
RNTXRein Therapeutics Inc.$0.4000-27.55%$34.5M
GRCEGrace Therapeutics Inc.$1.75-3.31%$36.8M
SERSerina Therapeutics Inc.$1.42+2.16%$37.7M
BMEABiomea Fusion Inc.$0.5201-10.67%$37.8M
HYPDHyperion DeFi Inc.$2.47-4.26%$38.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier